MoneyWorks4Me

Syncom Formulations (India) informs about board meeting

02 Nov 2019 Evaluate

With Reference to Regulation 29(1)(a) of SEBI (LODR) Regulations, 2015, Syncom Formulations (India) has informed that 3/2019-20 Meeting of the Board of directors of the Company is scheduled to be held on Thursday 14th November, 2019 at 4:00 PM at the Corporate office of the Company to consider and adopt the Standalone Unaudited Financial Results along with Limited Review Report by the Auditors of the company for the Half Year/ Quarter ended on 30th September, 2019 alongwith Statement of Assets and Liabilities and Statement of Cash Flow. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..